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Background: Krüppel-like factor 4 (KLF4) is a member of the KLF family of transcription factors and regulates
proliferation, differentiation, apoptosis and somatic cell reprogramming. Evidence also suggests that KLF4 is a tumor
suppressor in certain cancers including colorectal cancer. We previously showed that KLF4 inhibits cell cycle
progression following DNA damage and that mouse embryonic fibroblasts (MEFs) null for Klf4 are genetically
unstable, as evidenced by increased rates of cell proliferation, and the presence of DNA double strand breaks
(DSBs), centrosome amplification, chromosome aberrations and aneuploidy.
Methods: To determine whether re-expression of Klf4 corrects the observed genetic instability in MEFs null for Klf4
(Klf4−/−), we transfected Klf4−/−MEFs with Klf4-expressing plasmids and compared the results to wild type (Klf4+/+)
and untransfected or mock-transfected Klf4−/−MEFs.
Results: We show that overexpression of Klf4 in Klf4−/−MEFs reduced cell proliferation rates and the proportion of cells
with DSBs, abnormal centrosome numbers, aneuploidy and micronuclei. In addition, Klf4-transfected Klf4−/−MEFs
exhibited a more robust DNA damage repair response as demonstrated by the greater rate in disappearance of γ-H2AX
and 53BP1 foci following γ-irradiation.
Conclusion: Taken together these findings provide evidence that KLF4 plays a crucial role in the maintenance of genetic
stability by modulating the DNA damage response and repair processes.
Keywords: KLF4, Genetic instability, DNA damage responses, Aneuploidy, Centrosome amplification, Mouse embryonic
fibroblastsBackground
Krüppel-like factor 4 (KLF4) [1,2] belongs to the Krüppel-
like factor family of zinc-finger transcription factors that
are involved in numerous important cellular processes
such as growth, development, differentiation, proliferation,
inflammation, apoptosis, and somatic cell reprogramming.
KLF4 has been shown in a context-dependent manner to
be an oncogene or tumor suppressor [3], as respectively
demonstrated by the high levels of KLF4 in primary breast
ductal carcinoma and oral squamous cell carcinoma [4,5]
and decreased levels of KLF4 in a variety of other human
cancers including esophageal, gastric, bladder, pancreatic,
colorectal, lung and urinary bladder cancers [6-14].
We and others have reported that one of the functions
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reproduction in any medium, provided the orintegrity of the cell cycle [15]. KLF4 inhibits cell prolifer-
ation by functioning as a cell cycle checkpoint protein to
activate transcription of the cyclin-dependent kinase in-
hibitor, p21 [1,16]. Additionally, KLF4 is an important
mediator of p53-dependent growth arrest in the G1/S
and G2/M transitions of the cell cycle following DNA
damage [17]. More recently, we reported that KLF4 is
important for the maintenance of genetic stability. This
was demonstrated by the appearance of genetic instabil-
ity in mouse embryonic fibroblasts (MEFs) null for the
Klf4 gene in the forms of increased DNA double strand
breaks (DSBs), chromosomal aberrations and centro-
some amplification [18]. Since genetic instability plays a
crucial role in the development and progression of
human cancer [19], we sought to determine whether re-
expression of Klf4 in Klf4−/−MEFsMay correct the
observed genetic instability in these cells.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Re-expression of Klf4 in Klf4−/−MEFs reduces the rate of
cell proliferation
MEFs deficient for Klf4 are known to have a higher rate
of BrdU incorporation and apoptosis relative to wild
type cells [18]. We assessed whether re-expression
of Klf4 in Klf4−/−MEFs will affect the proliferative
capacity and or apoptosis. We first compared the
growth rates of Klf4-GFP-transfected Klf4−/− to mock-
or GFP-transfected Klf4−/−MEFs and to mock-, GFP-,
or Klf4-GFP-transfected Klf4+/+MEFs up to three
days after transfection. As shown in Figure 1A, in Klf4-
GFP-transfected Klf4−/−MEFs, cell proliferation was signifi-
cantly reduced compared to mock-transfected or GFP-
control-transfected Klf4−/− or Klf4+/+ cells up to three daysFigure 1 Growth characteristics of Klf4-transfected Klf4−/−MEFs in cult
not with various plasmids. Cells were initially seeded at 105 cells/plate in 60 mm
GFP control, or mock-transfected in parallel. Number of cells was counted (thre
of the MEFs from each transfection was determined at each time point and th
0.001 for Klf4+/+ and Klf4−/− cells transfected with Klf4-GFP compared to mock-
of apoptotic Klf4+/+ and Klf4−/−MEFs following GFP or Klf4-GFP overexpression.
GFP was done and number of cells that are positive for both were counted. N
Klf4-GFP compared to GFP-transfected Klf4−/− cells, p = 0.059). (C) Western blot
24 h post transfection of Klf4+/+ and Klf4−/− cells with GFP or Klf4-GFP.post-transfection. Proliferation of Klf4-GFP-transfected
Klf4+/+MEFs was also significantly reduced compared to
mock-transfected or GFP-control-transfected Klf4−/− and
Klf4+/+ cells. Recently, we demonstrated that Klf4−/−MEFs
have a higher level of apoptosis than Klf4+/+MEFs [18]. We
examined whether re-expression of Klf4 in Klf4−/−MEFs
has any effect on apoptosis level. We transfected Klf4-GFP
or GFP-control in Klf4+/+ and Klf4−/−MEFs, immuno-
stained them for cleaved caspase 3, and counted the num-
ber of GFP-positive cells that were positive for cleaved
caspase 3. As shown in Figure 1B, overexpression of
Klf4 has no apparent effect on the basal level of apop-
tosis in Klf4+/+MEFs transfected with Klf4-GFP as com-
pared to the control. Although overexpression of Klf4
in Klf4−/−MEFs lowered the apoptosis level comparedure. (A) Cell proliferation rates of Klf4+/+ and Klf4−/−MEFs, transfected or
plates. On day 0, cells were transfected in triplicates with pmKLF4-pEGFP,
e plates per transfection) every day over a total of 3 days. The growth rate
e values represent the mean number of cells per well. N = 3 (*** = p<
or GFP-transfected Klf4+/+ and Klf4−/− cells, respectively). (B) Quantification
At 24 h post-transfection, immunostaining for both cleaved caspase 3 and
= 3 (Difference did not reach significance for Klf4−/− cells transfected with
analysis of Klf4, p53, p21, cyclin E, γH2AX, and β-actin in protein extracts at
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reach statistically significant value (p = 0.059).
KLF4 has been shown to play an important role in the
regulation of cell cycle progression through modification of
expression levels of multiple proteins (e.g. p21, p53)
[3,20,21]. Since re-expressing Klf4 in Klf4−/−MEFs reduced
proliferation (Figure 1A), we hypothesized that re-
expression of Klf4 in Klf4−/−MEFs will affect the levels of
proteins involved in cell proliferation including p21. To
validate this hypothesis, we performed Western blot ana-
lysis in Klf4+/+, mock- or GFP-control-transfected Klf4−/−
and Klf4-GFP-transfected Klf4−/−MEFs’s. Additionally we
analyzed the levels of proteins involved in centrosome
amplification (p53 and cyclin E) and DNA damage (γ-
H2AX). It was previously shown that Klf4−/−MEFs have
lower levels of p21, increased levels of p53, cyclin E, and γ-
H2AX proteins in comparison to Klf4+/+MEFs [18,22,23].
As shown in Figure 1C, relative to Klf4+/+ cells,
Western blot analysis of mock- or GFP-control-transfected
Klf4−/−MEFs showed an absence of p21, and an increase in
p53, cyclin E, and γ-H2AX levels, similar to previous stud-
ies [18,22,23]. In contrast, Klf4-GFP-transfected Klf4−/−
cells had a higher level of p21 and reduced levels of p53,
cyclin E and γ-H2AX when compared to mock- or GFP-
control-transfected Klf4−/− cells (Figure 1C). These results
indicate that re-expression of Klf4 in Klf4−/−MEFs trends
toward restoring the levels of cell cycle regulatory proteins
and γ-H2AX to that of wild-type cells.Re-expression of Klf4 in Klf4−/−MEFs corrects centrosome
amplification
We previously showed that Klf4 plays a role in regulating
centrosome duplication in MEFs - whereas 2-3% of Klf4+/+
MEFs exhibited centrosome amplification, defined as the
presence of 3 or more centrosomes per cell, approximately
25% of the Klf4−/−MEFs had centrosome amplification,
[18]. To determine if re-expressing Klf4 corrects the nu-
merical centrosome abnormality in Klf4−/−MEFs, we
performed immunofluorescent staining of centrosomes
with an antibody against γ-tubulin. An example of the
results of such staining in Klf4+/+ and Klf4−/− is shown in
Figure 2A, which demonstrates the normal distribution of
2 centrosomes per cell in Klf4+/+MEFs but up to 8 centro-
somes in a Klf4−/−MEF. We quantified the total number of
cells with 3 or more centrosomes in Klf4+/+, GFP-
control-transfected Klf4−/−, and Klf4-GFP-transfected
Klf4−/−MEFs. As shown in Figure 2B, there was a sig-
nificant increase in cells with 3 or more centrosomes in
GFP-transfected Klf4−/− as compared to Klf4+/+ cells
(2-3% and 17%, respectively). Overexpression of Klf4 in
Klf4−/−MEFs significantly reduced the number of cells
with 3 or more centrosomes to an average of 7%. To
further demonstrate a direct link between Klf4 levelsand the extent of centrosome number correction, we
overexpressed Klf4-GFP in Klf4−/−MEFs and counted
only the cells that were positive for GFP and have ≥3
centrosomes. As shown in Figure 2C, overexpression of
Klf4-GFP in Klf4−/−MEFs resulted in a significant de-
crease in the percentage of cells with ≥3 centrosomes
compared to GFP-control-transfected Klf4−/−MEFs
(12% and 32%, respectively).Klf4 re-expression reduces γ-irradiation-induced DNA
damage in Klf4-/- MEFs
To determine the role of Klf4 in the DNA damage re-
sponse and repair process, we first evaluated the extent
of double strand breaks (DSBs) with and without γ-
irradiation in Klf4+/+ and Klf4−/−MEFs using γ-H2AX
and 53BP1 as markers of DNA damage. We induced
DNA damage with γ-irradiation and counted cells with
5 or more foci for each marker at 0, 1, 4, and 24h post
γ-irradiation. An example of γ-H2AX and 53BP1 stain-
ing in non-irradiated Klf4+/+ and Klf4−/−MEFs is shown
in Figure 3A. Approximately 25% of non-irradiated
Klf4+/+MEFs and 90% of Klf4−/−MEFs had ≥5 γ-H2AX
foci (Figure 3B). The number of cells with ≥5 γ-H2AX
foci was significantly increased at 1 and 4h post-irradiation
in Klf4+/+MEFs and then returned to the basal level by 24
h post-irradiation. In contrast, the number of cells with ≥5
γ-H2AX foci remained elevated in Klf4−/−MEFs up to
24 h post-irradiation. A similar trend was noted for
cells with ≥5 53BP1 foci in the two MEFs before and
after irradiation (Figure 3C). These results suggest that
while wild-type MEFs exhibit a normal DNA damage
response following γ-irradiation, cells lacking Klf4 have
persistent evidence of DNA damage.
We then determined if re-expression of Klf4 corrects
the DNA damage observed in Klf4−/−MEFs by
transfecting GFP-control or Klf4-GFP into Klf4−/−
cells. Figure 4A shows an example of GFP-positive
green cells with γ-H2AX and 53BP1 staining in GFP-
or Klf4-GFP-transfected Klf4−/−MEFs. As shown in
Figure 4B, at baseline, transfection of Klf4−/− cells with
Klf4-GFP significantly reduced the number of green
cells with γ-H2AX foci as compared to GFP-
transfected cells. At 1 and 4 h after irradiation, the
number of cells with γ-H2AX foci increased in Klf4-
GFP-transfected Klf4−/−MEFs and then returned to a
level below that of GFP-transfected MEFs at 24 h post-
irradiation. A similar trend is noted for 53BP1 except
that Klf4-GFP-transfectedMEFs had lower percentage
of cells with ≥5 53BP1 foci relative to GFP-transfected
cells at all time-points (Figure 4C). These data suggest
that re-expression of Klf4 in Klf4−/−MEFs results in a
more efficient repair of DNA damage compared to con-
trol Klf4−/− cells.
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We recently reported that Klf4−/−MEFs exhibited genetic
instability manifested by the presence of aneuploidy [18].
To determine whether re-expression of Klf4 corrects this
abnormality, we transfected Klf4−/−MEFs with Klf4-
expressing plasmids and performed cytogenetic analysis.
An example of metaphase chromosome spreads in Klf4+/+
and Klf4−/− is shown in Figure 5A. As seen in Figure 5B,Figure 2 Overexpression of Klf4 suppresses centrosome amplification
against γ-tubulin and detected with Alexa Fluor 488-conjugated antibody. Hoec
of centrosome staining of Klf4+/+ and Klf4−/− MEFs. The inset shows a Klf4+/+ cel
centrosomes (≥ 3). Shown is a typical result of 4 independent experiments. (B)
centrosomes in Klf4+/+, Klf4−/−, and GFP or Klf4-GFP transfected Klf4-/ -MEFs. One
0.05, ** p< 0.01 compared to Klf4+/+ cells. (C) A graph showing the percentage
centrosomes. One hundred green cells were counted per cell type per experimanalysis of metaphase chromosome spreads demon-
strated that while Klf4+/+MEFs showed a distribution
of chromosome numbers between the 35–44 and 75–
84 (approximating haploid and diploid, respectively),
Klf4−/−MEFs consistently had higher numbers of chro-
mosomes with many cells displaying greater than
95 chromosomes per cell, indicating the presence of
aneuploidy. Overexpression of Klf4 in Klf4−/−MEFs,in Klf4−/−MEFs. Centrosome staining was conducted with an antibody
hst stain (blue) was used to visualize the nuclei. (A) A representative image
l with 2 centrosomes and a Klf4−/− cell with abnormal number of
histogram showing quantification in percentages of cells with ≥3
hundred cells were counted per cell type per experiments. N = 5; * p<
of green Klf4−/− cells (positive for GFP-control or Klf4-GFP) with ≥3
ents. N = 5; * p< 0.05 compared to Klf4−/− cells transfected with GFP alone.
Figure 3 Immunostaining for γ-H2AX and 53BP1 in Klf4+/+ and Klf4−/−MEFs. (A) Immunostaining was conducted for γ-H2AX and 53BP1 in
Klf4+/+ and Klf4−/−MEFs. Non-irradiated Klf4+/+ and Klf4−/−MEFs were stained with antibodies against γ-H2AX and 53BP1 and hoechst stain (blue)
was used to visualize nuclei. Shown is a representative result of three independent experiments. (B) Histogram showing quantification of cells
with ≥ 5 γ-H2AX foci in Klf4+/+ and untransfected Klf4−/−MEFs with and without γ-irradiation. (C ) Histogram showing quantification of cells
with ≥ 5 53BP1 foci in Klf4+/+ and untransfected Klf4−/−MEFs with and without γ-irradiation. For (B) and (C), foci were counted for non-irradiated
cells, and at 1, 4 and 24h post irradiation. One hundred cells were counted per cell type per experiment. N = 5; * p < 0.05, ** p < 0.01 compared
to Klf4+/+ cells.
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exhibiting aneuploidy as compared to untransfected
Klf4−/− or GFP-control-transfected Klf4−/−MEFs.
Klf4 re-expression in Klf4-null MEFs decreases the number
of micronuclei
Micronuclei are formed due to DSBs and represent a
mechanism by which errors in chromosome segregation
and DNA breaks are eliminated from the nucleus of the
cell [24]. Given the increased proliferation rate, DNA
damage and aneuploidy observed in Klf4−/− in compari-
son with Klf4+/+MEFs, we further assessed the frequencyof micronuclei formation which can originate from DNA
breaks, chromosome fragments or lagging chromosomes
during aberrant cell division in Klf4−/−MEFs. We used
cytochalasin-B, an inhibitor of cytokinesis that allows easily
distinguishing between mononucleated non-dividing cells
and binucleated dividing cells. To examine the effect of
Klf4 on the frequency of binucleated cells containing
micronuclei in Klf4−/−MEFs, we overexpressed GFP-
control or Klf4-GFP in Klf4−/−MEFs and treated cells with
cytochalasin-B. At 24 h following cytochalasin-B addition,
we stained cells with Hoechst and analyzed only the green,
binucleated cells and quantified the frequency of cells with
Figure 4 Immunostaining for γ-H2AX and 53BP1 in Klf4−/−MEFs transfected with GFP or Klf4-GFP. (A) Immunostaining was conducted for
γ-H2AX and 53BP1 in Klf4−/−MEFs transfected with GFP or Klf4-GFP.hoechst stain (blue) was used to visualize nuclei. Shown is a representative result of
three independent experiments for the non-irradiated cells. (B) Histogram showing quantification of cells with ≥ 5 γ-H2AX foci in Klf4−/−MEFs cells
transfected with GFP or Klf4-GFP, with or without γ-irradiation. (C) Histogram showing quantification of cells with ≥ 5 53BP1 foci in Klf4−/−MEFs cells
transfected with GFP or Klf4-GFP, with or without γ-irradiation. For (B) and (C), foci were counted for non-irradiated cells, and at 1, 4 and 24 h post
irradiation. One hundred green cells were counted per cell type per experiment. N = 5; * p< 0.05, ** p < 0.01 compared to GFP-transfected Klf4−/− cells.
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taining micronuclei staining in Klf4+/+ and binucleated
green Klf4−/− cells is shown in Figure 6A. As shown in
Figure 6B, approximately 4% of Klf4+/+ cells have binu-
cleated cells with micronuclei, while 60-70% of GFP-
control-transfected Klf4−/−MEFs have binucleated cells
with micronuclei. Importantly, re-expression of Klf4-
GFP in Klf4−/−MEFs reduced the levels of binucleated
cells with micronuclei to 20-30% (Figure 6B).
Discussion
Previously, we demonstrated that deletion of Klf4
from MEFs cells leads to increased genetic instability.
Klf4−/−MEFs display significantly higher levels of DNA
damage as indicated by the increased presence of γ-
H2AX foci compared with Klf4+/+MEFs with and
without γ-irradiation [18,23]. Additionally, the loss of
Klf4 leads to defective cell-cycle checkpoint functions,
aberrant centrosome duplication and increased aneu-
ploidy. In view of these findings, we set to determineif reintroduction of Klf4 into Klf4−/−MEFs will correct
the observed genetic instable phenotype.
Cancer cells generally contain the full complement of
biomolecules that are necessary for survival, prolifera-
tion, differentiation, and cell death [25]. However, it is
the failure to regulate these functions that results in an
altered phenotype in cancer. Defects in checkpoint con-
trol increase genetic instability and contribute to uncon-
trolled proliferation. We have previously shown that
relative to wild-type cells, MEFs deficient in Klf4 had a
higher rate of BrdU incorporation that, was seemingly
offset by a higher level of apoptosis [18]. KLF4 is re-
quired for cell cycle arrest in G1, G2 or both in many cell
types by modulating expression of cell cycle regulatory
genes [16,17,26]. Moreover, transcriptional profiling of
KLF4 in cell lines suggests that KLF4 functions as a
negative regulator of cell cycle progression [27,28]. As
shown in Figure 1A, following Klf4 re-introduction in
Klf4−/−MEFs, the growth rate was significantly reduced.
Also, consistent with previous reports that KLF4 exerts
Figure 5 Determination of ploidy in Klf4+/+ and Klf4−/−MEFs. Karyotype analysis was conducted in metaphase chromosome spreads prepared
from Klf4+/+ and from Klf4−/−MEFs transfected or not with GFP or Klf4-GFP. (A) Shown is a typical result of three independent experiments for Klf4+/+ and
Klf4−/−MEFs. (B-E) Histograms showing quantification of chromosome number in Klf4+/+ and in Klf4−/−MEFs untransfected or transfected with GFP or Klf4-
GFP. Spreads from 100 cells were examined per genotype.
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of p21 [16,29], the level of p21 was upregulated when
compared to control Klf4−/−MEFs (Figure 1C). However,
given the modest p21 upregulation in Klf4-transfected
Klf4−/−MEFs when compared to control Klf4+/+MEFs
(Figure 1C), it is possible that such a robust inhibition of
cell proliferation observed in Klf4−/−MEFs following Klf4
over expression might not be attributed to a single factor
alone. In response to the high basal DNA damage and gen-
etic instability observed in Klf4−/−MEFs, such a robust
suppression of proliferation following Klf4 overexpression
could be the result of a cumulative effect of the
upregulation of additional cell-cycle progression inhibitorsthat have been shown to be upregulated by Klf4, such as
14-3-3-sigma [27] and other Cip/Kip family members p57
[27] and p27 [30], this in addition to the suppression of
promoters of the cell cycle progression such as cyclin E
(Figure 1C and [22]), cyclin B1 [26] and cyclin D1 [31],
Such notion requires further investigation.
We have previously shown that Klf4−/−have a higher level
of apoptosis than Klf4+/+MEFs [18,23]. Here we demon-
strated that overexpression of Klf4 has no apparent effect
on basal level of apoptosis in Klf4+/+but trended to reduce
apoptosis in Klf4−/−MEFs (Figure 1B). These results sug-
gest that under basal conditions, overexpression of Klf4 in
cells with endogenous Klf4has no additional advantage on
Figure 6 Determination of micronuclei (MN) formation in MEFs. Micronuclei (MN) analysis was conducted in cytokinesis-arrested cells
prepared from Klf4+/+ and from Klf4−/−MEFs transfected with GFP or Klf4-GFP. (A) Klf4+/+ and Klf4−/−MEFs transfected with GFP or Klf4-GFP were
treated with cytochalasin-B (CCB) and Hoechst stain (blue) was used to visualize nuclei. Shown are representative images of cells containing MN.
(B) Histogram showing quantification of percent of binucleated cells with MN 24h post CCB treatment. At least 200 green cells were counted for
each genotype per experiment. N = 3; *** p < 0.001 compared to GFP-transfected Klf4−/− cells.
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absence of endogenous Klf4 might be advantageous to cell
survival by reducing the apoptotic level.
Abnormal duplication of centrosomes is a major rea-
son for chromosome instability in cancer because it
leads to multipolar spindles which direct unequal segre-
gation of chromosomes during mitosis, thus increasing
the frequency of mitotic defects [32,33]. We have previ-
ously shown that Klf4 plays a role in regulating centro-
some duplication in MEFs as evidenced by the presence
of centrosome amplification (defined as ≥3 centrosomes
per cell) in Klf4−/−MEFs when compared to Klf4+/+MEFs[18]. Centrosome amplification occurs when its duplication
becomes dysregulated. It is known that the p53-p21-cyclin
E axis of pathway plays a major role in regulating centro-
some duplication. p53 is a tumor suppressor that induces
the expression of p21 [34,35], which inhibits the activity of
Cdk2/cyclin E [36]. Previous work has shown that disrup-
tion of this pathway (loss of p53 or p21, or overexpression
of cyclin E) can induce centrosome amplification [37]. Re-
cently, we demonstrated that genetic instability in the ab-
sence of Klf4 is likely due to elevated cyclin E and p53
levels, which are normally suppressed by Klf4 [18]. The
current study demonstrates that Klf4 may play a role in
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−/−MEFs. A potential mechanism by which this is achieved
is indicated by the results in which Klf4 overexpression in
Klf4−/−MEFs lowered the levels of p53 and cyclin E and in-
creased that of p21, cumulating in a restoration of the nor-
mal centrosome duplication process.
The DNA damage response (DDR) is essential for the
maintenance of genetic stability and an unstable genome
leads to the accumulation of mutations and cancer de-
velopment [38,39]. Inefficient DNA double-strand break
(DSB) repair can result in chromosomal translocation,
deletion and chromosome fusion or loss [40]. DDR sig-
naling involves a large number of proteins that act as
sensors, mediators, transducers and effector proteins
[41,42]. Recruitment of the DDR protein γ-H2AX,
BRCA1, and 53BP1 to DNA DSBs is a key event in the
DDR [43-45]. Defective recruitment of repair factors at
DNA DSBs, such as delay in foci assembly and disassem-
bly, is associated with defective DDR. Klf4−/−MEFs
contain a high level of phosphorylated histone 2AX (y-
H2AX), a marker for double-strand DNA breaks, and
exhibit chromosome aberrations including dicentric chro-
mosomes, double minute chromosomes, and chromatid
breaks [18]. The current study shows that a significantly
higher fraction of Klf4−/−MEFs contained γ-H2AX foci as
compared to Klf4+/+MEFs over 24 h in response to γ-
irradiation (Figure 3B). In Klf4−/−MEFs we observed no
appreciable DNA repair response, showing a persistently
elevated percentage of cells with 53BP1 foci 24 h post-
irradiation compared to a robust DNA repair response in
Klf4+/+MEFs post irradiation (Figure 3C). These results
suggest that Klf4 may be involved in the DNA repair re-
sponse. This role is further substantiated by the ability of
Klf4 to correct DNA damage present in Klf4−/−MEFs after
its reintroduction as demonstrated by lower number of
foci of both γ-H2AX and 53BP1 with and without irradi-
ation (Figure 4B and C). Taken together these results sug-
gest that KLF4 plays a role in repairing DNA damage but
the exact mechanism by which KLF4 accomplishes this re-
quires further exploration.
Genetic instability, which includes both numerical
and structural chromosomal abnormalities, is a hall-
mark of cancer. We recently reported that Klf4−/−MEFs
exhibit aneuploidy [18]. The current study demon-
strated a role of Klf4 in preserving genetic integrity by
correcting aneuploidy in Klf4−/−MEFs. Re-expression of
Klf4 in Klf4−/− cells resulted in a decrease in the num-
ber of cells exhibiting aneuploidy when compared to
control Klf4−/−MEFs (Figure 5). The role of KLF4 in
maintaining genetic stability is further substantiated by
the ability of Klf4 to suppress micronuclei formation in
Klf4−/− cells (Figure 6) as micronuclei is considered a
biomarker of chromosomal damage, genome instability,
and eventually of cancer risk [46]. The mechanism bywhich Klf4 maintain ploidy and chromosome integrity
is currently being investigated.
Conclusion
In summary, our lab previously identified KLF4 as a poten-
tial tumor suppressor in colorectal cancer in which KLF4
level is reduced in tumor tissues relative to normal tissues
[13]. Moreover, in a large cohort of colon cancer, loss of
KLF4 expression is an indicator for poor prognosis includ-
ing survival [47]. These results are consistent with the ob-
servations of the current study showing that KLF4 has an
important function in maintaining genetic stability. Import-
antly results of our study also indicate that re-expression of
KLF4 reverts the genetic instability encountered in cells
that have lost the KLF4 gene. These results suggest that ap-
proaches to increase KLF4 levels may potentially serve as a
novel therapeutic option for colorectal cancer.
Methods
Cells and cell culture
The wild type (Klf4+/+) and null (Klf4−/−) for Klf4 mouse
embryonic fibroblasts (MEFs) were generated as previously
described [23]. Studies involving experimental animals
have been reviewed and approved by the Stony Brook Uni-
versity Institutional Review Board (Protocol #245765).
Cells were Maintained in Dulbecco’s Modified eagle’s
Medium (DMEM) supplemented with 10% FBS, 1% peni-
cillin/streptomycin at 37°C in atmosphere containing 5%
CO2. To overexpress Klf4-GFP and GFP-control in MEFs,
cells were transiently transfected with 3 μg plasmid DNA
(per well in a 6-well plate) or 0.6 μg plasmid DNA (per well
in a 4-well glass slide) using Lipofectamine 2000 reagent
(Life Technologies) according to Manufacturer’s instruc-
tions. For cell proliferation assay, cells were seeded onto 6-
well plates at a density of 105 cells per well in triplicate.
Cells were harvested by trypsinization every 24 h for 3 days
and counted using Z1 Coulter Particle Counter (Beckman
Coulter). For DNA-damage analysis cells were treated or
not with γ-irradiation using 137Cs -irradiator at 0.75 Gy/
min for a total of 2 Gy. Media were refreshed and treated
cells were allowed to recover for 1, 4 or 24 h before fixation
for immunostaining.
Plasmids
Expression vector pEGFP-N1 was purchased from
Clontech. For generation of Klf4-GFP fusionMKLF4
ORF was excised from pGBKT7-Klf4 vector [48] using
NcoI and EcoRI restriction enzymes. ExcisedMKlf4 ORF
was then inserted in frame in pRSET B vector, and the
stop codon of theMKlf4 was removed by PCR site di-
rected mutagenesis. TheMKlf4minus stop codon was
then excised using KpnI restriction enzyme and inserted
in pEGFP-N1.
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Cytogenetic analysis by Metaphase spreading of MEFs
was performed as described previously [49]. Colcemid
(0.5 μg/ml, Life Technologies) was added to MEFs 4 h be-
fore harvesting. After treatment, floating rounded-up Mi-
totic and adherent cells (obtained from the Medium and a
PBS wash or after trypsinization, respectively) were pooled
and pelleted by centrifugation at 10,000 rpm for 5 min.
Cells were swollen in hypotonic solution (0.075 M KCl) at
37°C for 15 min and fixed in fresh, Carnoy’s fixative
(methanol: glacial acetic acid at 3:1) for 10 min at room
temperature. Cells were spun down at 1000 rpm for 10
min, and washed three times in Carnoy’s fixative and then
dropped onto glass slides and aged in a 60°C oven over-
night. Cells were subjected to hoechst staining for nucleus
visualization. Metaphase spreads images were acquired
using a Nikon eclipse 90iMicroscope (Nikon Instruments
Inc.) equipped with a DS-Qi1Mc and DS-Fi1, CCD cam-
eras (Nikon Instruments Inc.). The numbers of chromo-
somes in Metaphase (n = 100 cells) from each genotype
were counted and analyzed.
Immunofluorescence analysis
For all the immunostaining experiments, cells grown on
glass coverslips were washed briefly with PBS and fixed
with 3.7% formaldehyde for 30 min at room temperature
followed by three times wash with PBS. For centrosome
count, at 24 h post-transfection, untransfected and
transfected cells were fixed and washed as mentioned
above. Cells were then incubated with blocking solution
(3% bovine serum albumin (BSA), 0.2% Triton X-100 in
PBS) for 1 h at room temperature, probed with rabbit
anti-γ-tubulin polyclonal antibody (10732; Santa Cruz)
overnight at 4°C and detected with Alexa Fluor 568-
conjugated goat anti-rabbit IgG antibody (A11011, Life
Technologies) for 1 h at 37°C. Cells were then washed
once and counterstained with hoechst for 5 min at room
temperature in the dark. Finally cells were washed two
times and Mounted in Prolong Antifade kit (Life Tech-
nologies), and visualized with Nikon microscope. Anti-
body dilutions and washes after incubations were
performed in blocking solution. For γH2AX and 53BP1
foci staining, cells were transfected as mentioned above,
and left untreated or γ-irradiated (2 Gy) at 24 h post-
transfection, and incubated for 1, 4, or 24 h. Cells were
fixed and immunostaining was carried out as Men-
tioned above. Cells were probed with Mouse anti-
γH2AXMonoclonal antibody (05–636; Millipore) or rabbit
anti-53BP1 polyclonal antibody (ab21083, Abcam) over-
night at 4°C, and detected with Alexa Fluor 568-
conjugated goat anti-mouse IgG antibody or Alexa Fluor
568-conjugated goat anti-rabbit IgG antibody, respectively,
for 1 h at 37°C. For cleaved caspase 3 staining, cells were
transfected as Mentioned above. At 24 h post-transfection,cells were fixed and immunostaining was carried out as
Mentioned above. Cells were probed with rabbit anti-
cleaved caspase 3 polyclonal antibody (9664S, Cell signal-
ing) overnight at 4°C and detected with Alexa Fluor 568-
conjugated goat anti-rabbit IgG antibody for 1 h at 37°C.Micronucleus assay
Cells were seeded onto coverslips and transfected as men-
tioned above. Five hours post transfection cells were
treated with 4 μg/ml cytochalasin B (C6762, Sigma) in
fresh media and incubated overnight. At 24 h post-
cytochalasin B addition, cells were stained with hoechst for
5 min at room temperature in the dark. Finally cells were
washed two times mounted in Prolong Antifade kit (Life
Technologies) and visualized with Nikon microscope.
Immunoblotting
Cells were lysed in lyses buffer containing 100 mm
Tris–HCl (pH6.8), 2% sodium dodecyl sulfate (SDS)
and 20% glycerol, and vortexed for 3–4 min for
homogenization. Insoluble material was removed by centri-
fugation at 12,000 rpm for 5 min, and the supernatant was
collected for protein quantification. Following quantifica-
tion, β-mercaptoethanol and bromophenol blue were
added to a final concentration of 5% (v/v) and 0.1% (w/v),
respectively, and samples were heated at 95-100°C for 10
min. Samples were cooled to room temperature and then
used for SDS-PAGE gel electrophoresis. Following protein
transfer, the membranes were immunoblotted with the fol-
lowing primary antibodies: rabbit anti-KLF4 (PM07,MBL),
goat anti-p53 (6243, Santa Cruz), Mouse anti-p21 (556431,
BD Biosciences), Mouse anti-cyclin E (05–363, Millipore),
and rabbit anti-γH2AX (05–636, Millipore), and mouse
anti-β-actin (A1978, Sigma-Aldrich). The blots were then
incubated with appropriate horseradish peroxidase-
conjugated secondary antibodies for 1 h at room
temperature. The antibody-antigen complex was visual-
ized by ECL chemiluminescence (Millipore).Statistical analysis
Statistical analysis for significance between treatments
was performed by t-test.Competing interests
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